BioSpace News Archive

Immunis Inc., a private biotechnology company developing a novel treatment for age and disease-related immune decline, today announced that the U.S. Food and Drug Administration has approved it’s Investigational New Drug application for a Phase 1/2a clinical trial investigating IMM01-STEM in participants with muscle atrophy.

EndoGastric Solutions, Inc.® today announced that the American Gastroenterology Association retired their 2008 guidelines, Management of Gastroesophageal Reflux Disease and released a Clinical Practice Update (CPU), which includes the TIF 2.0 procedure as an effective endoscopic option for patients with troublesome regurgitation or heartburn who do not wish to undergo anti-reflux surgery, and who do not have severe reflux esophagitis.

Cellworks Group, Inc., today announced results from the myCare-203A study, which demonstrate that the Cellworks Biosimulation Platform and Singula™ Therapy Response Index (TRI) was strongly predictive of Overall Survival (OS) for non-small cell lung cancer (NSCLC) patients and can provide personalized therapy decision guidance.

Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), is pleased to report that, further to its news releases of June 21, 2022 and July 18, 2022, it has closed its non-brokered private placement of 7,200,000 units of the Company (the “Units”) at a price of $0.10 per Unit for aggregate gross proceeds of $720,000 (the “Offering”).

Today, New England Biolabs (NEB®) announces the release of the Faustovirus Capping Enzyme (FCE), an mRNA capping solution that combines high activity and a broad temperature range to support mRNA therapeutic manufacturing needs.

The latest market analysis report published by Reports and Data, titled ‘Global Sturge Weber Syndrome Market – Forecast to 2030,’ thoroughly examines the Sturge Weber Syndrome industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Fallopian Tube Cancer Market – Forecast to 2030,’ thoroughly examines the Fallopian Tube Cancer industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Dysthymia Market – Forecast to 2030,’ thoroughly examines the Dysthymia industry to provide essential data & information for the targeted readers.

Today InsightRX, a high-growth healthcare technology company that provides cloud-based clinical decision support for point-of-care precision dosing, announced its partnership with Healix, the national leader in physician office-based infusion services.

The latest market analysis report published by Reports and Data, titled ‘Global Diabetes Insipidus Market – Forecast to 2030,’ thoroughly examines the Diabetes Insipidus industry to provide essential data & information for the targeted readers.